nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—neck—salivary gland cancer	0.031	0.0599	CbGeAlD
Amiloride—SCNN1G—parotid gland—salivary gland cancer	0.0284	0.0547	CbGeAlD
Amiloride—SCNN1G—saliva-secreting gland—salivary gland cancer	0.0272	0.0524	CbGeAlD
Amiloride—ASIC1—saliva-secreting gland—salivary gland cancer	0.0267	0.0514	CbGeAlD
Amiloride—SLC9A1—saliva-secreting gland—salivary gland cancer	0.0255	0.0493	CbGeAlD
Amiloride—AOC1—connective tissue—salivary gland cancer	0.0245	0.0472	CbGeAlD
Amiloride—SCNN1B—parotid gland—salivary gland cancer	0.024	0.0462	CbGeAlD
Amiloride—SCNN1D—epithelium—salivary gland cancer	0.0237	0.0457	CbGeAlD
Amiloride—SLC9A1—connective tissue—salivary gland cancer	0.0235	0.0453	CbGeAlD
Amiloride—SCNN1B—saliva-secreting gland—salivary gland cancer	0.0229	0.0443	CbGeAlD
Amiloride—SLC9A1—epithelium—salivary gland cancer	0.0223	0.043	CbGeAlD
Amiloride—PLAU—connective tissue—salivary gland cancer	0.0222	0.0429	CbGeAlD
Amiloride—SCNN1A—parotid gland—salivary gland cancer	0.0221	0.0427	CbGeAlD
Amiloride—SCNN1A—saliva-secreting gland—salivary gland cancer	0.0212	0.0409	CbGeAlD
Amiloride—PLAU—epithelium—salivary gland cancer	0.0211	0.0407	CbGeAlD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC24A3—salivary gland cancer	0.0211	0.0438	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—ITGB4—salivary gland cancer	0.0208	0.0432	CbGpPWpGaD
Amiloride—SCNN1B—epithelium—salivary gland cancer	0.02	0.0386	CbGeAlD
Amiloride—PLAU—FGF signaling pathway—IL17RD—salivary gland cancer	0.0193	0.04	CbGpPWpGaD
Amiloride—SCNN1A—epithelium—salivary gland cancer	0.0185	0.0357	CbGeAlD
Amiloride—SLC9A1—lymphoid tissue—salivary gland cancer	0.0172	0.0331	CbGeAlD
Amiloride—PLAU—Wnt Signaling Pathway—WNT5B—salivary gland cancer	0.0168	0.0348	CbGpPWpGaD
Amiloride—PLAU—lymphoid tissue—salivary gland cancer	0.0163	0.0314	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—CRTC1—salivary gland cancer	0.0156	0.0325	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—SMARCA2—salivary gland cancer	0.0129	0.0267	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—WNT5B—salivary gland cancer	0.012	0.0249	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—WNT5B—salivary gland cancer	0.0114	0.0236	CbGpPWpGaD
Amiloride—SLC22A4—neck—salivary gland cancer	0.0109	0.021	CbGeAlD
Amiloride—SCNN1D—lymph node—salivary gland cancer	0.0103	0.0199	CbGeAlD
Amiloride—ASIC1—lymph node—salivary gland cancer	0.0101	0.0195	CbGeAlD
Amiloride—AOC1—lymph node—salivary gland cancer	0.0101	0.0195	CbGeAlD
Amiloride—SLC9A1—lymph node—salivary gland cancer	0.00968	0.0187	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00958	0.0199	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00942	0.0196	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MYB—salivary gland cancer	0.0093	0.0193	CbGpPWpGaD
Amiloride—PLAU—lymph node—salivary gland cancer	0.00917	0.0177	CbGeAlD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—ST3GAL4—salivary gland cancer	0.0089	0.0185	CbGpPWpGaD
Amiloride—SCNN1B—lymph node—salivary gland cancer	0.0087	0.0168	CbGeAlD
Amiloride—PLAU—FGF signaling pathway—FGFR4—salivary gland cancer	0.00838	0.0174	CbGpPWpGaD
Amiloride—SCNN1A—lymph node—salivary gland cancer	0.00804	0.0155	CbGeAlD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00726	0.0151	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00726	0.0151	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00726	0.0151	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00726	0.0151	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00726	0.0151	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—BRCA1—salivary gland cancer	0.00671	0.0139	CbGpPWpGaD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—VCAN—salivary gland cancer	0.00636	0.0132	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—PYGB—salivary gland cancer	0.00609	0.0126	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—BRCA1—salivary gland cancer	0.00566	0.0118	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FGF16—salivary gland cancer	0.00559	0.0116	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—MAP2K2—salivary gland cancer	0.00557	0.0116	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—JMJD1C—salivary gland cancer	0.00499	0.0104	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00479	0.00994	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—ST3GAL4—salivary gland cancer	0.00478	0.00992	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0044	0.00913	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00431	0.00895	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—salivary gland cancer	0.00422	0.00877	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—CDH1—salivary gland cancer	0.00419	0.00869	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.00413	0.00856	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—FOXO3—salivary gland cancer	0.00397	0.00823	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—salivary gland cancer	0.00389	0.00807	CbGpPWpGaD
Amiloride—SLC9A1—RhoA signaling pathway—PTEN—salivary gland cancer	0.00386	0.00802	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—ATM—salivary gland cancer	0.00381	0.00792	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAP2K2—salivary gland cancer	0.0037	0.00768	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00349	0.00724	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—NUP62—salivary gland cancer	0.00344	0.00714	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00343	0.00712	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—VCAN—salivary gland cancer	0.00341	0.00709	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00333	0.00692	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00333	0.00692	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00333	0.00692	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00333	0.00692	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00333	0.00692	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CREBBP—salivary gland cancer	0.00331	0.00688	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—PIK3CA—salivary gland cancer	0.00331	0.00688	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.00322	0.00669	CbGpPWpGaD
Amiloride—SLC22A4—lymph node—salivary gland cancer	0.00322	0.00621	CbGeAlD
Amiloride—PLAU—Hemostasis—GUCY1A3—salivary gland cancer	0.00321	0.00667	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—GAS6—salivary gland cancer	0.00321	0.00667	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.00291	0.00604	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.0028	0.0058	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ATM—salivary gland cancer	0.00277	0.00575	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00268	0.00556	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00264	0.00549	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00264	0.00549	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00264	0.00549	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00264	0.00549	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00264	0.00549	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—CCND1—salivary gland cancer	0.00263	0.00545	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CREBBP—salivary gland cancer	0.00254	0.00527	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00254	0.00527	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00245	0.00508	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—EP300—salivary gland cancer	0.00233	0.00485	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—EP300—salivary gland cancer	0.00226	0.00469	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0022	0.00456	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00219	0.00455	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—PIK3CA—salivary gland cancer	0.00213	0.00441	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00204	0.00423	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—HRAS—salivary gland cancer	0.00193	0.004	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MYB—salivary gland cancer	0.00191	0.00397	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ISYNA1—salivary gland cancer	0.00191	0.00396	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0019	0.00395	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND1—salivary gland cancer	0.00188	0.0039	CbGpPWpGaD
Amiloride—SLC9A1—Disease—WNT5B—salivary gland cancer	0.00179	0.00371	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND1—salivary gland cancer	0.00178	0.00369	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PTEN—salivary gland cancer	0.00177	0.00367	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00174	0.00362	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—EP300—salivary gland cancer	0.00173	0.00359	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PYGB—salivary gland cancer	0.00173	0.00358	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL17RD—salivary gland cancer	0.00173	0.00358	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CPSF4—salivary gland cancer	0.00173	0.00358	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PTEN—salivary gland cancer	0.00172	0.00357	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—salivary gland cancer	0.00167	0.00347	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAML3—salivary gland cancer	0.00158	0.00328	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00157	0.00326	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MARCKS—salivary gland cancer	0.00155	0.00323	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PYGB—salivary gland cancer	0.00144	0.003	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00141	0.00293	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—salivary gland cancer	0.00138	0.00287	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ST3GAL4—salivary gland cancer	0.00135	0.00281	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00135	0.00281	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—HRAS—salivary gland cancer	0.00128	0.00266	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—salivary gland cancer	0.00124	0.00257	CbGpPWpGaD
Amiloride—SLC9A1—Disease—DTX4—salivary gland cancer	0.00123	0.00255	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—salivary gland cancer	0.00121	0.00252	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.00121	0.00251	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PHGDH—salivary gland cancer	0.00118	0.00245	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—salivary gland cancer	0.00117	0.00243	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.00116	0.0024	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ST3GAL4—salivary gland cancer	0.00113	0.00235	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—salivary gland cancer	0.00112	0.00233	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00105	0.00217	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00104	0.00215	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AQP1—salivary gland cancer	0.00103	0.00214	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00103	0.00213	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00103	0.00213	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00103	0.00213	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00103	0.00213	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00103	0.00213	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF16—salivary gland cancer	0.00102	0.00211	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00101	0.00209	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NUP62—salivary gland cancer	0.000975	0.00202	CbGpPWpGaD
Amiloride—SLC9A1—Disease—VCAN—salivary gland cancer	0.000967	0.00201	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000966	0.00201	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAML2—salivary gland cancer	0.000883	0.00183	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NUP62—salivary gland cancer	0.000816	0.00169	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—VCAN—salivary gland cancer	0.00081	0.00168	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000798	0.00166	CbGpPWpGaD
Amiloride—SLC9A1—Disease—JAG1—salivary gland cancer	0.000754	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR4—salivary gland cancer	0.000751	0.00156	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000742	0.00154	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FBXW7—salivary gland cancer	0.000739	0.00153	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CREBBP—salivary gland cancer	0.000704	0.00146	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000692	0.00144	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000676	0.0014	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FOXO3—salivary gland cancer	0.000623	0.00129	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAP2K2—salivary gland cancer	0.000509	0.00106	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—EP300—salivary gland cancer	0.00048	0.000996	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000476	0.000988	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000443	0.000921	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOTCH1—salivary gland cancer	0.000417	0.000866	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ISYNA1—salivary gland cancer	0.000413	0.000857	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ISYNA1—salivary gland cancer	0.000385	0.000798	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CREBBP—salivary gland cancer	0.000378	0.000785	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000377	0.000783	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—salivary gland cancer	0.000355	0.000737	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000352	0.00073	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—salivary gland cancer	0.000343	0.000713	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MARCKS—salivary gland cancer	0.000336	0.000698	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—salivary gland cancer	0.000328	0.000682	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CREBBP—salivary gland cancer	0.000317	0.000657	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MARCKS—salivary gland cancer	0.000314	0.000651	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PYGB—salivary gland cancer	0.000313	0.000649	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000309	0.000642	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PYGB—salivary gland cancer	0.000291	0.000605	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—salivary gland cancer	0.00027	0.00056	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EP300—salivary gland cancer	0.000257	0.000534	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PHGDH—salivary gland cancer	0.000255	0.000529	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ST3GAL4—salivary gland cancer	0.000245	0.000509	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PHGDH—salivary gland cancer	0.000238	0.000493	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ST3GAL4—salivary gland cancer	0.000229	0.000475	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—salivary gland cancer	0.000226	0.000469	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AQP1—salivary gland cancer	0.000223	0.000463	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—EP300—salivary gland cancer	0.000216	0.000448	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AQP1—salivary gland cancer	0.000208	0.000431	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—salivary gland cancer	0.00019	0.000395	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NUP62—salivary gland cancer	0.000177	0.000367	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—salivary gland cancer	0.000176	0.000366	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—VCAN—salivary gland cancer	0.000175	0.000364	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000166	0.000344	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NUP62—salivary gland cancer	0.000165	0.000342	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—VCAN—salivary gland cancer	0.000163	0.000339	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—salivary gland cancer	0.000159	0.000331	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000154	0.00032	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000146	0.000304	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000136	0.000283	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—salivary gland cancer	0.000127	0.000263	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—salivary gland cancer	0.000118	0.000245	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CREBBP—salivary gland cancer	6.85e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CREBBP—salivary gland cancer	6.39e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—salivary gland cancer	4.89e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EP300—salivary gland cancer	4.67e-05	9.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—salivary gland cancer	4.56e-05	9.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EP300—salivary gland cancer	4.35e-05	9.03e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—salivary gland cancer	3.45e-05	7.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—salivary gland cancer	3.22e-05	6.68e-05	CbGpPWpGaD
